FIM
PTLA

Fernwood Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Fernwood Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-325,645
Closed -$2.32M – 171
2020
Q1 		$2.32M Sell
325,645
-10,466
-3% -$131K 1.48% 17
2019
Q4 		$8.03M Sell
336,111
-39,700
-11% -$1.1M 3.84% 2
2019
Q3 		$10.1M Sell
375,811
-6,100
-2% -$171K 5% 2
2019
Q2 		$10.4M Sell
381,911
-5,100
-1% -$160K 5.67% 2
2019
Q1 		$13.4M Buy
387,011
+46,748
+14% +$1.35M 7.17% 2
2018
Q4 		$6.64M Buy
340,263
+110,885
+48% +$2.28M 4.28% 3
2018
Q3 		$6.11M Buy
229,378
+1,980
+0.9% +$64.6K 3.23% 3
2018
Q2 		$8.59M Sell
227,398
-1,475
-0.6% -$56.4K 4.64% 3
2018
Q1 		$7.47M Buy
228,873
+296
+0.1% +$13K 4.17% 3
2017
Q4 		$11.1M Sell
228,577
-1,000
-0.4% -$50.6K 5.95% 3
2017
Q3 		$12.4M Sell
229,577
-9,300
-4% -$546K 7.77% 2
2017
Q2 		$13.4M Buy
238,877
+10,975
+5% +$440K 9.73% 1
2017
Q1 		$8.93M Sell
227,902
-12,450
-5% -$397K 7.11% 2
2016
Q4 		$5.39M Buy
240,352
+3,600
+2% +$70.3K 5.17% 1
2016
Q3 		$5.38M Buy
236,752
+3,800
+2% +$89.2K 4.93% 1
2016
Q2 		$5.5M Buy
232,952
+38,100
+20% +$941K 5.39% 1
2016
Q1 		$3.98M Sell
194,852
-11,159
-5% -$354K 4.03% 3
2015
Q4 		$10.6M Buy
206,011
+16,000
+8% +$776K 9.06% 1
2015
Q3 		$8.1M Sell
190,011
-11,200
-6% -$540K 7.1% 1
2015
Q2 		$9.16M Sell
201,211
-11,000
-5% -$443K 7.2% 1
2015
Q1 		$8.06M Sell
212,211
-24,700
-10% -$848K 6.62% 1
2014
Q4 		$6.71M Sell
236,911
-3,000
-1% -$83.4K 5.71% 1
2014
Q3 		$6.07M Buy
239,911
+15,000
+7% +$395K 5.22% 1
2014
Q2 		$6.56M Buy
224,911
+106,530
+90% +$2.58M 5.42% 1
2014
Q1 		$3.07M Sell
118,381
-102,201
-46% -$2.73M 2.84% 5
2013
Q4 		$5.68M Buy
+220,582
New +$5.36M 3.77% 1

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Fernwood Investment Management's PTLA Position: Q2 2020 in Review

Fernwood Investment Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 325,645 shares — an estimated $2.32M sold.

Fernwood Investment Management first reported a position in PTLA in Q4 2013 and held it in 26 quarters. The position peaked at $13.4M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Fernwood Investment Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Fernwood Investment Management sold 325,645 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $2.32M.
  • Fernwood Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 26 quarters.
  • Fernwood Investment Management's Portola Pharmaceuticals, Inc. position peaked at $13.4M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Fernwood Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.